Jefferies Financial Group Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 96223
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$11,501,286
+$869,169 QoQ
Shares Held
23,154
-2.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#341
of 1,735 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Dec 31, 2023CallValue
$5,045,436
CallShares
12,400
PutValue
$3,621,321
PutShares
8,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. VRTX ranks #13 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,357,042 | $110,693,915 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $80,947,193 | |
| 3 | IMTX |
Immatics N.V.
|
6,506,802 | $65,913,904 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
2,010,534 | $62,849,292 | |
| 5 | CGON |
CG Oncology, Inc.
|
769,947 | $54,704,734 | |
| 6 | ARGX |
Argenx SE
|
45,068 | $41,812,738 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
929,626 | $31,040,212 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
466,258 | $26,679,282 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,501,286 | 23,154 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $10,632,117 | 23,810 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $14,222,809 | 31,372 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $6,266,240 | 16,000 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,410,598 | 34,615 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,446,232 | 19,484 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $5,631,356 | 13,984 | Shares | Defined | 2025-02-27 | |
| 2024-09-30 | $15,181,606 | 32,643 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $28,252,098 | 60,275 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $23,752,164 | 56,822 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,045,436 | 12,400 | Call | Defined | 2024-05-06 | |
| 2023-12-31 | $7,327,275 | 18,008 | Shares | Defined | 2024-05-06 | |
| 2023-12-31 | $3,621,321 | 8,900 | Put | Defined | 2024-05-06 | |
| 2023-09-30 | $3,129,660 | 9,000 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $1,356,186 | 3,900 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $104,669 | 301 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,847,432 | 10,933 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $105,573 | 300 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $3,554,291 | 10,100 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $3,504,838 | 11,124 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $6,301,400 | 20,000 | Put | Defined | 2023-05-15 | |
| 2022-12-31 | $2,162,384 | 7,488 | Shares | Defined | 2023-09-21 | |
| 2022-12-31 | $5,833,356 | 20,200 | Put | Defined | 2023-09-21 | |
| 2022-12-31 | $1,501,656 | 5,200 | Call | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||